Cargando…
Evolution of affinity between p53 transactivation domain and MDM2 across the animal kingdom demonstrates high plasticity of motif‐mediated interactions
The interaction between the transcription factor p53 and the ubiquitin ligase MDM2 results in the degradation of p53 and is well‐studied in cancer biology and drug development. Available sequence data suggest that both p53 and MDM2‐family proteins are present across the animal kingdom. However, the...
Autores principales: | Mihalič, Filip, Åberg, Emma, Farkhondehkish, Pouria, Theys, Niels, Andersson, Eva, Jemth, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303687/ https://www.ncbi.nlm.nih.gov/pubmed/37211711 http://dx.doi.org/10.1002/pro.4684 |
Ejemplares similares
-
Evolution of the p53-MDM2 pathway
por: Åberg, Emma, et al.
Publicado: (2017) -
Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2
por: Teufel, Daniel P., et al.
Publicado: (2009) -
Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
por: Jordan, Jennifer J., et al.
Publicado: (2008) -
High affinity between CREBBP/p300 and NCOA evolved in vertebrates
por: Karlsson, Elin, et al.
Publicado: (2020) -
Correction: Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
por: Jordan, Jennifer J., et al.
Publicado: (2008)